📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor. (2021)

First Author: Skwarska A

Attributed to: Chemical biology tools for investigating the chemistry of cellular REDOX stress funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.chembiol.2021.04.004

PubMed Identifier: 33910023

Publication URI: http://europepmc.org/abstract/MED/33910023

Type: Journal Article/Review

Volume: 28

Parent Publication: Cell chemical biology

Issue: 9

ISSN: 2451-9448